Pharmacokinetics and Bioequivalence of Two Empagliflozin, With Evaluation in Healthy Jordanian Subjects Under Fasting and Fed Conditions

NACompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

May 17, 2021

Primary Completion Date

December 10, 2021

Study Completion Date

December 12, 2021

Conditions
Pharmacokinetic Parameters
Interventions
DRUG

Empagliflozin 10 mg Tab

The Empagliflozin 10 mg Tab were administered orally. The plasma concentrations of empagliflozin were determined using an HPLC-MS/MS method. Tolerability and safety were assessed throughout the study. This study included 26 subjects, 26 in each fasting and fed group.

Trial Locations (1)

11196

Wael Abu Dayyih, Amman

All Listed Sponsors
lead

Mutah University

OTHER